Second Genome Appoints Dr. Susannah Cantrell to Chief Business Officer and Dr. Preeti Gupta Lal to Chief Scientific Officer

January 25, 2021, Brisbane, CA

Read More

Second Genome To Present Biomarker Data in Oncology at Keystone Symposium

January 19, 2021, South San Francisco, CA

Read More

Second Genome To Present at Biotech Showcase Digital 2021 Conference

January 11, 2021, South San Francisco, CA

Read More

Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery

April 6, 2020, Foster City, CA & South San Francisco, CA

Read More

FORTUNE and Great Place to Work Name Second Genome a "Top 10 Best Workplace in Biopharma"

April 10, 2019, South San Francisco, CA

Read More

Second Genome Expands Development of CNS Platform to Validate Microbial Products as Therapeutics for Autism Spectrum Disorder

March 26, 2019, South San Francisco

Read More

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For The Treatment Of Nonalcoholic Steatohepatitis (NASH)

January 23, 2019, South San Francisco

Read More

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer

September 26, 2018, South San Francisco, CA

Read More